 Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1995 | 2 | 4 | 6 | | 1996 | 0 | 4 | 4 | | 1997 | 3 | 1 | 4 | | 1998 | 2 | 1 | 3 | | 1999 | 1 | 2 | 3 | | 2000 | 4 | 2 | 6 | | 2001 | 1 | 3 | 4 | | 2002 | 3 | 1 | 4 | | 2003 | 6 | 2 | 8 | | 2004 | 2 | 3 | 5 | | 2005 | 9 | 1 | 10 | | 2006 | 3 | 3 | 6 | | 2007 | 5 | 1 | 6 | | 2008 | 9 | 8 | 17 | | 2009 | 8 | 6 | 14 | | 2010 | 14 | 4 | 18 | | 2011 | 3 | 8 | 11 | | 2012 | 9 | 5 | 14 | | 2013 | 11 | 12 | 23 | | 2014 | 22 | 12 | 34 | | 2015 | 17 | 7 | 24 | | 2016 | 17 | 10 | 27 | | 2017 | 15 | 7 | 22 | | 2018 | 16 | 13 | 29 | | 2019 | 14 | 8 | 22 | | 2020 | 18 | 16 | 34 | | 2021 | 15 | 22 | 37 | | 2022 | 2 | 25 | 27 | | 2023 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Salehi Omran S. Cervical Artery Dissection. Continuum (Minneap Minn). 2023 04 01; 29(2):540-565.
-
Stettler GR, Sumislawski JJ, Debot M, Moore EE, Burlew CC. Low-Dose Heparin Infusion as Venous Thromboembolism Chemoprophylaxis in Patients With Blunt Cerebrovascular Injury. J Surg Res. 2023 06; 286:1-7.
-
Massoud GP, Hazimeh DH, Amin G, Mekary W, Khabsa J, Araji T, Fares S, Mericskay M, Booz GW, Zouein FA. Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review. Eur J Pharmacol. 2023 Feb 15; 941:175501.
-
Zghaib T, Allison JD, Barrett C, Arkles J, D'Souza B, Luebbert J, Garcia F, Heist EK, Tzou W, Callans D, Marchlinski FE, Frankel DS. Multicenter experience with andexanet alfa for refractory pericardial bleeding during catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2023 03; 34(3):593-597.
-
Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. Blood. 2022 12 22; 140(25):2722-2729.
-
Westerman ME, Bree KK, Msaouel P, Kukreja JB, Mantaring C, Rukundo I, Gonzalez MG, Gregg JR, Casteel KN, Matin SF. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study. J Urol. 2022 10; 208(4):886-895.
-
Bonaca MP, Antman EM, Cunningham JW, Wiviott SD, Murphy SA, Halperin JL, Weitz JI, Grosso MA, Lanz HJ, Braunwald E, Giugliano RP, Ruff CT. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29; 8(7):695-706.
-
Borst JM, Modi RN, Kirchberg TN, Box K, Smith AM, Godat LN, Doucet JJ, Costantini TW, Berndtson AE. You're never too old for optimal venous thromboembolism prophylaxis: Re-thinking current trauma guidelines. Thromb Res. 2022 10; 218:186-188.
-
Whipple MO. Review of Article: CRISTAL Study Group. Effect of aspirin vs. enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: The CRISTAL randomized trial. JAMA. 2022;328(8):719-727. J Vasc Nurs. 2022 09; 40(3):155-156.
-
Siegler JE, Shu L, Yaghi S, Salehi Omran S, Elnazeir M, Bakradze E, Psychogios M, De Marchis GM, Yu S, Klein P, Abdalkader M, Nguyen TN. Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis. Neurosurgery. 2022 11 01; 91(5):749-755.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|